Study Stopped
COVID, death of investigator
Effects of Osteopathic Manipulative Treatment in Chronic Non-allergic Rhinosinusitis
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
Chronic Rhinosinusitis (CRS) is a chronic condition with limited therapeutic options. Moreover, the pathophysiology is poorly understood. The aim of this study is to evaluate the efficacy of osteopathic manipulative treatment (OMT) in the course of this condition by applying several techniques supposed to be related to the autonomic nervous system. Our hypothesis is that these techniques could have beneficial effects on inflammation and head symptoms in CRS. Methods: A sample of 90 patients diagnosed by ENT specialist will be randomly assigned to the OMT group or the placebo group. The placebo procedure will consist in using light touch around the nose, on the throat and on the thorax. Treatment and placebo protocols are composed of two visits at day 0 and day 30. A general practitioner will determine the eligibility for the study. The outcomes include Peak Nasal Inspiratory Flow (PNIF) measured five times: at day 0, 30 (twice each, before and after treatment) and 180 (once). The two groups will be compared regarding short and long term evolution. The evolution of symptoms will be assessed by the Sino-nasal Outcome Test (SNOT-22) seven times: at day 0, 30, 60, 90, 120, 150 and 180. This outcome will be analyzed using mixed effect modelling A Qualitative study will be conducted in the two groups to understand the patients' experiences during care. This protocol has been approved by a french ethic committee (Comité de Protection des Personnes Sud Ouest et Outre-Mer II, 2020.04.09).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedStudy Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedAugust 1, 2023
July 1, 2023
11 months
May 28, 2020
July 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in peak nasal inspiratory flow (PNIF)
The aim of this outcome is to measure change in nasal airflow during maximal inspiration with a facial mask.
PNIF will be perform at day 0 (before treatment) and at day 30 (before treatment)
Secondary Outcomes (4)
Change in Sino-nasal Outcomes Test 22 (SNOT-22)
Patients will complete the questionnaire at baseline (day 0), day 30, day 60, day 90, day 120, day 150 and day 180 to assess the change over time
Patient-reported experience of care
Interview will occur at day 180
Sort term change in peak nasal inspiratory flow (PNIF)
PNIF will be perform at day 0 (before and after treatment), day 30 (before and after treatment)
long term change in peak nasal inspiratory flow (PNIF)
PNIF will be perform at day 0 (before treatment) and at day 180.
Study Arms (2)
OMT group
EXPERIMENTALPlacebo group
PLACEBO COMPARATORInterventions
Osteopaths will executed several high velocity low amplitude (HVLA) techniques on the upper thoracic spine and cervical spine. These techniques are assumed to modulate the sympathetic cervical ganglia and reduce inflammation in chronic rhinosinusitis. This procedure takes around 15 minutes.
The osteopath will lay hands without movement on the nose, the throat and the thorax of patients. This procedure takes around 15 minutes.
Eligibility Criteria
You may qualify if:
- age between 18 and 50
- Chronic rhinosinusitis diagnosed by ear, nose, and throat (ENT) specialist or general practitioner
- informed consent given
- registered under french social security system
You may not qualify if:
- contraindication to spine manipulation
- receiving other treatment for CRS during this study
- being pregnant
- being under legal protection
- withdrawal of consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cabinet ORL du Maine
Le Mans, 72000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
sebastien cambier
Institut des Hautes Etudes Osteopathiques de Nantes
- STUDY DIRECTOR
maxime salmon, MsC
Institut des Hautes Etudes Osteopathiques de Nantes
- STUDY CHAIR
Marie Moreau
Institut des Hautes Etudes Osteopathiques de Nantes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The care provider knows the assignment of patient. In order to know if the blinding was effective, at the end of each treatment, patient will have to tell if they were in the placebo or the OMT group
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2020
First Posted
June 9, 2020
Study Start
July 1, 2021
Primary Completion
June 1, 2022
Study Completion
June 30, 2022
Last Updated
August 1, 2023
Record last verified: 2023-07